227 related articles for article (PubMed ID: 20861457)
1. Cooperation of tissue factor cytoplasmic domain and PAR2 signaling in breast cancer development.
Schaffner F; Versteeg HH; Schillert A; Yokota N; Petersen LC; Mueller BM; Ruf W
Blood; 2010 Dec; 116(26):6106-13. PubMed ID: 20861457
[TBL] [Abstract][Full Text] [Related]
2. Role of protease activated receptor 1 and 2 signaling in hypoxia-induced angiogenesis.
Uusitalo-Jarvinen H; Kurokawa T; Mueller BM; Andrade-Gordon P; Friedlander M; Ruf W
Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1456-62. PubMed ID: 17363687
[TBL] [Abstract][Full Text] [Related]
3. Tissue factor in cancer progression and angiogenesis.
Ruf W; Yokota N; Schaffner F
Thromb Res; 2010 Apr; 125 Suppl 2(0 2):S36-8. PubMed ID: 20434002
[TBL] [Abstract][Full Text] [Related]
4. Protease-activated receptor (PAR) 2, but not PAR1, signaling promotes the development of mammary adenocarcinoma in polyoma middle T mice.
Versteeg HH; Schaffner F; Kerver M; Ellies LG; Andrade-Gordon P; Mueller BM; Ruf W
Cancer Res; 2008 Sep; 68(17):7219-27. PubMed ID: 18757438
[TBL] [Abstract][Full Text] [Related]
5. Regulation of angiogenesis by tissue factor cytoplasmic domain signaling.
Belting M; Dorrell MI; Sandgren S; Aguilar E; Ahamed J; Dorfleutner A; Carmeliet P; Mueller BM; Friedlander M; Ruf W
Nat Med; 2004 May; 10(5):502-9. PubMed ID: 15098027
[TBL] [Abstract][Full Text] [Related]
6. Tissue factor cytoplasmic domain exacerbates post-infarct left ventricular remodeling via orchestrating cardiac inflammation and angiogenesis.
Chong SY; Zharkova O; Yatim SMJM; Wang X; Lim XC; Huang C; Tan CY; Jiang J; Ye L; Tan MS; Angeli V; Versteeg HH; Dewerchin M; Carmeliet P; Lam CSP; Chan MY; de Kleijn DPV; Wang JW
Theranostics; 2021; 11(19):9243-9261. PubMed ID: 34646369
[TBL] [Abstract][Full Text] [Related]
7. Tissue factor and PAR2 signaling in the tumor microenvironment.
Schaffner F; Ruf W
Arterioscler Thromb Vasc Biol; 2009 Dec; 29(12):1999-2004. PubMed ID: 19661489
[TBL] [Abstract][Full Text] [Related]
8. Hematopoietic tissue factor-protease-activated receptor 2 signaling promotes hepatic inflammation and contributes to pathways of gluconeogenesis and steatosis in obese mice.
Wang J; Chakrabarty S; Bui Q; Ruf W; Samad F
Am J Pathol; 2015 Feb; 185(2):524-35. PubMed ID: 25476527
[TBL] [Abstract][Full Text] [Related]
9. The cytoplasmic domain of tissue factor in macrophages augments cutaneous delayed-type hypersensitivity.
Apostolopoulos J; Hickey MJ; Sharma L; Davenport P; Moussa L; James WG; Gregory JL; Kitching AR; Li M; Tipping PG
J Leukoc Biol; 2008 Apr; 83(4):902-11. PubMed ID: 18180372
[TBL] [Abstract][Full Text] [Related]
10. Neutrophil activation by the tissue factor/Factor VIIa/PAR2 axis mediates fetal death in a mouse model of antiphospholipid syndrome.
Redecha P; Franzke CW; Ruf W; Mackman N; Girardi G
J Clin Invest; 2008 Oct; 118(10):3453-61. PubMed ID: 18802482
[TBL] [Abstract][Full Text] [Related]
11. Protease-activated receptor 2-dependent phosphorylation of the tissue factor cytoplasmic domain.
Ahamed J; Ruf W
J Biol Chem; 2004 May; 279(22):23038-44. PubMed ID: 15039423
[TBL] [Abstract][Full Text] [Related]
12. Thrombin generation and the pathogenesis of cancer.
Ruf W; Mueller BM
Semin Thromb Hemost; 2006 Apr; 32 Suppl 1():61-8. PubMed ID: 16673267
[TBL] [Abstract][Full Text] [Related]
13. Evidence for tissue factor phosphorylation and its correlation with protease-activated receptor expression and the prognosis of primary breast cancer.
Rydén L; Grabau D; Schaffner F; Jönsson PE; Ruf W; Belting M
Int J Cancer; 2010 May; 126(10):2330-40. PubMed ID: 19795460
[TBL] [Abstract][Full Text] [Related]
14. Engineering of substrate selectivity for tissue factor.factor VIIa complex signaling through protease-activated receptor 2.
Larsen KS; Ostergaard H; Olsen OH; Bjelke JR; Ruf W; Petersen LC
J Biol Chem; 2010 Jun; 285(26):19959-66. PubMed ID: 20388709
[TBL] [Abstract][Full Text] [Related]
15. Cytoplasmic domain of tissue factor promotes liver fibrosis in mice.
Knight V; Lourensz D; Tchongue J; Correia J; Tipping P; Sievert W
World J Gastroenterol; 2017 Aug; 23(31):5692-5699. PubMed ID: 28883694
[TBL] [Abstract][Full Text] [Related]
16. The tick-derived inhibitor Ixolaris prevents tissue factor signaling on tumor cells.
Carneiro-Lobo TC; Schaffner F; Disse J; Ostergaard H; Francischetti IM; Monteiro RQ; Ruf W
J Thromb Haemost; 2012 Sep; 10(9):1849-58. PubMed ID: 22823596
[TBL] [Abstract][Full Text] [Related]
17. Regulation of macrophage procoagulant responses by the tissue factor cytoplasmic domain in endotoxemia.
Ahamed J; Niessen F; Kurokawa T; Lee YK; Bhattacharjee G; Morrissey JH; Ruf W
Blood; 2007 Jun; 109(12):5251-9. PubMed ID: 17332247
[TBL] [Abstract][Full Text] [Related]
18. Expression of tissue factor signaling pathway elements correlates with the production of vascular endothelial growth factor and interleukin-8 in human astrocytoma patients.
Carneiro-Lobo TC; Lima MT; Mariano-Oliveira A; Dutra-Oliveira A; Oba-Shinjo SM; Marie SK; Sogayar MC; Monteiro RQ
Oncol Rep; 2014 Feb; 31(2):679-86. PubMed ID: 24297570
[TBL] [Abstract][Full Text] [Related]
19. PAR2-SMAD3 in microvascular endothelial cells is indispensable for vascular stability via tissue factor signaling.
Arderiu G; Espinosa S; Peña E; Aledo R; Badimon L
J Mol Cell Biol; 2016 Jun; 8(3):255-70. PubMed ID: 26658897
[TBL] [Abstract][Full Text] [Related]
20. Tissue factor trafficking in fibroblasts: involvement of protease-activated receptor-mediated cell signaling.
Mandal SK; Pendurthi UR; Rao LV
Blood; 2007 Jul; 110(1):161-70. PubMed ID: 17384202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
